Ibandronic Acid is a generic version of Bonviva (Ibandronic Acid) from Roche.
The product is indicated for the treatment of osteoporosis in postmenopausal women at increased risk of fracture.
Teva commercial director Kim Innes said, "We’ve now launched 21 products this year including ten on day one of patent expiry, in a variety of strengths and pack sizes."
Ibandronic Acid is available in the Teva 360 livery.